Oppenheimer & CO Inc Medi Wound Ltd. Transaction History

Oppenheimer & CO Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$3.77 - $6.05 $146,653 - $235,345	-38,900 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.12 - $4.08 $5,304 - $6,936	1,700 Added 4.57%	38,900 $144,000
Q3 2020 Nov 13, 2020	SELL	$3.09 - $4.14 $12,360 - $16,560	-4,000 Reduced 9.71%	37,200 $140,000
Q1 2020 May 08, 2020	SELL	$1.57 - $3.1 $4,710 - $9,300	-3,000 Reduced 6.79%	41,200 $65,000
Q4 2019 Feb 07, 2020	SELL	$2.72 - $3.15 $11,968 - $13,860	-4,400 Reduced 9.05%	44,200 $137,000
Q3 2019 Oct 31, 2019	BUY	$2.58 - $3.97 $12,384 - $19,056	4,800 Added 10.96%	48,600 $156,000
Q2 2019 Aug 09, 2019	BUY	$3.0 - $5.5 $33,000 - $60,500	11,000 Added 33.54%	43,800 $148,000
Q1 2019 Apr 24, 2019	BUY	$4.24 - $5.24 $8,480 - $10,480	2,000 Added 6.49%	32,800 $164,000
Q2 2018 Aug 10, 2018	SELL	$5.05 - $7.35 $10,100 - $14,700	-2,000 Reduced 6.1%	30,800 $213,000
Q1 2018 May 01, 2018	SELL	$3.9 - $5.5 $10,530 - $14,850	-2,700 Reduced 7.61%	32,800 $171,000
Q4 2017 Feb 07, 2018	BUY	$4.25 - $5.2 $39,100 - $47,840	9,200 Added 34.98%	35,500 $158,000
Q3 2017 Nov 09, 2017	BUY	$4.8 - $6.95 $126,240 - $182,785	26,300	26,300 $141,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $798M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.